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Patient: A patient with severe-to-profound mixed hearing
loss, who was not benefiting from the use of a conventional
hearing aid, was selected for an inner ear active implant.
This was justified by a bone conductive threshold above
60 dB, which had discouraged any other rehabilitative
solutions such as a bone conductive implant, or an active
middle ear implant (AMEI).
Intervention: The hearing device was surgically applied
using a combined transmastoid/transcanal approach. During
surgery, a mobile stapes were found and was perforated for
the insertion of a piston prosthesis, crimped on the new-
incus of the device.
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1the contralateral ear
masked. The hearing outcome was assessed soon after the
implant activation (6 weeks after surgery), and 6 months
after surgery.
Results: Upon activation of the device, a PTA4 of 45 dB
was obtained (at 0.5, 1, 2 and 4 kHz). At 6 months after
surgery, the speech discrimination score reached 90% at
80 dB SPL.
Conclusion: The application of the CodacsTM device has
shown to be compatible with a mobile stapes footplate, as
demonstrated in this report. The footplate perforation did not
cause any further hearing deterioration, and has allowed to
achieve a favorable auditory outcome. Key Words:
Codacs—Implantable hearing device—Mixed hearing loss.Otol Neurotol 37:xxx–xxx, 2016.ilitation of a mixed hearing loss has A new device has recently been intThe auditory rehab
recently become the target of several implanting centers
worldwide. Today, choosing the most appropriate device
is mostly on the basis of the bone-conductive (BC)
threshold which, up to a certain level (30–35 dB), could
benefit from a BC device: either conventional, fitted in
hearing spectacles, or bone-anchored. This latter system
is featured by differently powered processors, the most
powerful of which would theoretically be appropriate for
BC thresholds beyond 40 to 45 dB. However, at these
levels, recent reports have emphasized the favorable role
played by an active middle ear implant (AMEI), either
placed on the remnants of the ossicular chain or in contact
with the round window membrane (1). Nevertheless, also
an AMEI seems to work only up to certain BC levels, for
example, 65 dB at 4 kHz for the Vibrant Soundbridge,
showing much less or no efficacy for BC thresholds
beyond these limits. These are, therefore, regarded to
be an option for cochlear implants.roduced for bridging
this indication gap, and has initially been applied to the
most frequent pathology that causes an auditory condition
of this kind, i.e., otosclerosis (2–5). This device has been
experimentally shown to possess an extremely powerful
actuator, providing a direct acoustic cochlear stimulation
that bypasses the anatomical,middle ear conductive appar-
atus, and delivers the stimulation energy directly to the
inner ear fluids (3). Previous literature reports have
reported that this device may provide a substantial benefit
when the BC threshold is still measurable, but lies beyond
the indication range for a BC implant or an AMEI.
More recently, this hearing device has been proposed
in pathologies or surgical sequels other than otosclerosis.
In particular, its application has been associated as a
functional, sequential step to a subtotal petrosectomy, in
which case one might assume that, even in absence of
ossicular remnants, the stapes footplate would mostly be
unaffected and therefore mobile (6).
The purpose of the present article is to report a case of
application of an inner ear hearing active device on a
subject with severe-to-profound mixed hearing loss that
did not originate from otosclerosis or from sequels of
chronic otitis media, and in whom the stapes was intra-
operatively found to be mobile.horized reproduction of this article is prohibited.
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2 M. BARBARA ET AL.CASE REPORT
A 46-year-old man presented with bilateral mixed
hearing loss of a moderate degree in the right ear, and
of a severe degree in the left ear (Fig. 1). He had
undergone two previous transcanal ear surgeries on the
left ear, performed elsewhere by a single surgeon. No
intraoperative findings of stapes fixation were reported,
so that the surgeon decided not to proceed with any
specific stapedioplasty procedure. However, after the
second operation, an audiogram revealed a marked
deterioration of the BC threshold in the operated ear,
with a low discrimination score that had initially
prompted a rehabilitative attempt with an air-conduction
conventional hearing aid. Unfortunately, owing to its
poor beneficial effect, the patient had to abandon the
hearing aid and looked for alternative rehabilitative
solutions. At our implanting center, a Codacs (Cochlear,
Melbourne, Australia) device was proposed and its sur-
gical application was performed via a combined trans-
mastoid/transcanal approach (5). As anticipated from the
previous surgical reports, the stapes was found to be
mobile. So, after its disarticulation from the incus, this
latter was removed after using it as a reference for the
distance of the Codacs neo-incus actuator to the foot-
plate. Then, the stapes crura were resected with a laser
(Revolix jr, Lisa Laser, Katlenburg-Lindau, Germany) at
a power of 7W. Afterwards, the same laser was used to
carbonize the footplate at its mid-portion (2.5W), regu-
larizing the hole with a manual perforator. A 6.00mm
long, 0.4-mm wide stapes prosthesis (AudioTechnolo-
gies, Gossolengo, Italy) was then anchored to the Codacs
new-incus actuator, and then crimped. The immediate
postoperative BC threshold was observed to be
unchanged with respect to the preoperative levelCopyright © 2016 Otology & Neurotology, Inc. Unauthorized
FIG. 1. Left, Preoperative pure tone audiogram of the Codacs candidat
Codacs implanted patient. AC indicates air conduction; BC, bone cond
Otology & Neurotology, Vol. xx, No. xx, 2016(Fig. 1). Six weeks after surgery, at the activation of
the device, a PTA4 of 45 dB was obtained in sound field
(250, 500, 1000 and 2000Hz), with the contralateral ear
occluded, showing a remarkable improvement over the
unaided situation (Fig. 2). The speech discrimination
score, obtained whereas the contralateral ear was masked
(100 dB SPL), and performed at activation of the device
(i.e., 6 weeks after surgery), showed 20% of discrimi-
nation at 80 dB, which improved up to 90% at the
6-month follow-up control (Fig. 3).
DISCUSSION
Nowadays, the auditory rehabilitation of severe-to-
profound hearing loss is more likely to be obtained via
cochlear implantation (CI), including cases that are still
presenting with a conductive component, with a poor BC
threshold, and a low discrimination score. The efficacy of
a CI in end-stage otosclerosis has also been reported (7).
However, in the CI-implanted otosclerotic patients, a
higher percentage of facial nerve stimulation can occur,
obliging to deactivate some of the electrodes, with an
eventual decrease of the auditory improvement.
Additionally, from a subjective point of view, one
may assume that the perception of an electrical stimu-
lation could be different from the one that is received
acoustically. In this respect, recent reports have
suggested that in patients of advanced otosclerosis,
applying a protocol that consists of a standard stapedot-
omy and a successive hearing aid could be still advan-
tageous for the patient before proposing a CI (8,9).
For the same reason, a powerful inner ear active implant
has been auspicated for these advanced otosclerotic
patients, and has so far been applied in a discreet number
of patients at selected otologic implanting centers (2–5). reproduction of this article is prohibited.
e; right, immediate postoperative bone conduction threshold of the
uction.
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FIG. 2. Left, unaided sound field pure tone threshold of the Codacs implanted patient; right, Codacs-aided sound field pure tone
threshold of the implanted patient.
CODACS WITH A MOBILE STAPES 3From these preliminary clinical experiences, it has been
demonstrated that it provides a high-powered electrome-
chanical stimulation, and as clear and natural a sound as
one would expect from an acoustic stimulation. However,
it cannot yet be predicted whether the progression of
otosclerotic disease will later on necessitate a CI.Copyright © 2016 Otology & Neurotology, Inc. Unaut
FIG. 3. Left, unaided postoperative speech audiogram of the Codacs
the device, 6 weeks after surgery, showed a 20% of discrimination at 8
speech audiogram performed 6 months after surgery, showed a 90% o
masked.From a surgical point of view, in these otosclerotic
patients, the handling of the stapes footplate strictly
resembles what is performed in conventional stapes
surgery. As such, its perforation can be performed
via manual instruments, electric drills, or lasers. The
footplate manipulation in non-otosclerotic patients is,horized reproduction of this article is prohibited.
implanted patient; middle, the speech audiogram at activation of
0 dB of stimulation, with the contralateral ear masked; right, the
f discrimination at 80 dB of stimulation, with the contralateral ear
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4 M. BARBARA ET AL.contrarily, considered a potential hearing-threatening
maneuver.
A few years ago, Fisch et al. (10) proposed treating
these patients with conductive hearing loss and an absent
incus, with the positioning of a piston prosthesis crimped
on an artificial titanium rod (neo-malleus) inserted
through the reconstructed eardrum. This procedure could
also include perforation of a nearly normal and mobile
stapes. Although it has not been popularized, the author
demonstrated that footplate perforation and placement of
a stapes prosthesis in patients with a mobile footplate
were feasible, without running greater risks to the inner
ear in otosclerotic patients. Some similarities can easily
be found between the passive Fisch prosthesis and
the inner ear active implant presented in this report.
The latter is in fact implemented with an artificial rod
tip (new-incus), on which a piston prosthesis is crimped,
that acts as the actuator for an acoustic, electromechan-
ical stimulation.
The patient of the present report was offered the
opportunity to receive an active inner ear device owing
to his hearing impairment that was not having any
benefit from a conventional hearing aid, and to his initial
refuse to undergo CI surgery. The progression of his
hearing loss still remains controversial. In fact, initially,
history was in favor of the presence of an ossicular
fixation although stapes fixation was not found during
the two previous surgeries. Whether the cochlear
deterioration, expressed by the low bone conduction
threshold, was due to the original pathology or to the
previous surgeries is also not very clear. As a matter of
fact, during the present surgical procedure, a mobile
stapes was encountered, needing two separate laser-
assisted maneuvers: first, the removal of the crura, then
the perforation of the footplate. Despite the possible
risks related to the manipulation of a mobile stapes, the
early postoperative assessment revealed an unchanged
BC threshold, in agreement with what has earlier been
described by Fisch et al. (10) with a passive prosthesis,
and with the recent report of sequential application
after subtotal petrosectomy (6). It further needs to beCopyright © 2016 Otology & Neurotology, Inc. Unauthorized
Otology & Neurotology, Vol. xx, No. xx, 2016elucidated whether this device could also be indicated to
the failures from stapes surgery that end up with a
deterioration of the BC threshold beyond the indication
range of a BCI or an AMEI.
It is possible to conclude that the present inner ear
active hearing device represents a powerful tool that
enables a significant hearing improvement not only in
patients of otosclerosis but also when the stapes footplate
is mobile. This device could, therefore, be used for
patients with severe-to-profound, mixed hearing loss,
as an intermediate option between stapedotomy/conven-
tional hearing aid and CI.
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